Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
Autoimmune Disorders01:29

Autoimmune Disorders

2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maintaining innovation: How to make sewer robots and innovation policy work in Barcelona.

Social studies of science·2023
Same author

[Neurological manifestations in patients with severe COVID-19 in a tertiary care center].

Revista medica del Instituto Mexicano del Seguro Social·2021
Same author

[The neurology of COVID-19].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2021
Same author

Association of mitochondrial variants A4336G of the tRNAGln gene and 8701G/A of the MT-ATP6 gene in Mexicans Mestizos with Parkinson disease.

Folia neuropathologica·2020
Same author

Biochemical Characteristics of Bone Mineral Metabolism before and throughout the First Year after Kidney Transplantation, Persistent Hyperparathyroidism, and Risk Factors in a Latin Population.

International journal of endocrinology·2020
Same author

[The Hospital de Especialidades "Bernardo Sepúlveda Gutiérrez", and the generation of knowledge].

Revista medica del Instituto Mexicano del Seguro Social·2016
Same journal

[Importance of early detection and prevention of secondary immunodeficiency in children with HIV].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

Rethinking tuberculosis: Microbiological and immunological crossroads in the post-pandemic era.

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Symmetrical flexural and intertriginous rash related to corticosteroids].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Consensus of Mexican experts on long-term prophylaxis in patients with hereditary angioedema in Mexico].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Hypersensitivity to iodinated contrast media: Diagnostic and therapeutic strategies. Position Statement of the Drug Allergy Committee of the Mexican College of Clinical Immunology and Allergy].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Analysis of scientific production on asthma - COPD overlap syndrome].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

[Multiple sclerosis: current immunological aspects].

Carlos Cuevas-García1

  • 1Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Dirección General, Ciudad de México, México. cacu61152@hotmail.com.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|February 12, 2017
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) is a chronic central nervous system disease. Future therapies for MS aim to induce immune tolerance and promote remyelination for better treatment outcomes.

Keywords:
Adaptive immune responseCentral nervous system diseasesMultiple sclerosis

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Related Experiment Videos

Last Updated: Mar 7, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Area of Science:

  • Neuroimmunology
  • Neurodegenerative diseases
  • Central nervous system disorders

Background:

  • Multiple sclerosis (MS) is the leading cause of disability in young adults, characterized by chronic inflammation and neurodegeneration.
  • The exact causes of MS are unknown but involve environmental, viral, genetic, and immune factors leading to autoimmunity.
  • The disease affects 11-20 per 100,000 people in Mexico.

Purpose of the Study:

  • To review the immune response and neurodegeneration in multiple sclerosis.
  • To analyze the inflammatory cascade and demyelination process.
  • To discuss current and future therapeutic strategies for MS.

Main Methods:

  • Literature review of immune reaction components in MS.
  • Analysis of neurodegenerative processes in MS.
  • Examination of the inflammatory cascade and demyelination.

Main Results:

  • Current treatments focus on modulating the adaptive immune response (B and T cells).
  • Neuroinflammation and neurodegeneration are key pathological features.
  • Demyelination is driven by an inflammatory cascade.

Conclusions:

  • Future therapies should focus on antigen-specific immune tolerance induction (e.g., peptide, DNA, or nanoparticle vaccines).
  • Therapeutic strategies must also target innate immune components (microglia, macrophages, astrocytes) and promote remyelination.
  • An optimized treatment approach requires a combined strategy targeting inflammation and neurodegeneration, alongside biomarker monitoring.